Literature DB >> 17089218

Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease.

Mustafa Caliskan1, Sema Yilmaz, Erkan Yildirim, Hakan Gullu, Dogan Erdogan, Ozgur Ciftci, Gamze Kaynar, Eftal Yucel, Haldun Muderrisoglu.   

Abstract

Oral apthous ulcers and skin lesions are the primary symptoms of Behcet's disease (BD). To date, there is no study to investigate possible associations between these lesions and endothelial functions. We have hypothesized that active BD period with oral and skin lesions might have more deteriorating effect on endothelial functions. Thirty-five patients with BD were registered for the study. Each subject was evaluated two times in both active and inactive disease periods. The subject with at least 30 days of lesion-free period was regarded in the inactive disease period, and the subject with any oral and/or skin lesions was regarded in the active disease period. For the control group, 35 healthy age- and sex-matched subjects were registered. In each subject, flow-mediated dilation (FMD) of the brachial artery after transient ischemia was evaluated in both active and inactive disease periods. High-sensitivity C-reactive protein (hsCRP) values (3.30 +/- 5.76 vs 14.19 +/- 13.55 vs 1.82 +/- 1.31, P < 0.001) and FMD values (13.89 +/- 5.57 vs 8.53 +/- 4.78 vs 15.83 +/- 5.29, P < 0.001) were significantly different among the BD patients in inactive and active disease periods and among control subjects. FMD values in inactive and active disease periods modestly correlated to hsCRP and low-density lipoprotein cholesterol values. Brachial FMD is more prominently impaired in BD patients within the active disease period. BD patients are possibly more vulnerable to cardiovascular manifestations when they are in the active disease period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089218     DOI: 10.1007/s10067-006-0449-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  16 in total

1.  Vascular endothelial function and plasma homocysteine levels in Behcet's disease.

Authors:  Ramazan Ozdemir; Irfan Barutcu; Alpay T Sezgin; Nusret Acikgoz; Necip Ermis; Ali Metin Esen; Ergun Topal; Emrah Bariskaner; Ibrahim Ozerol
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

Review 2.  Behçet's disease and cardiovascular involvement.

Authors:  F Atzeni; P Sarzi-Puttini; A Doria; L Boiardi; N Pipitone; C Salvarani
Journal:  Lupus       Date:  2005       Impact factor: 2.911

3.  Vascular involvement in Behçet's disease.

Authors:  Y Koç; I Güllü; G Akpek; T Akpolat; E Kansu; S Kiraz; F Batman; T Kansu; F Balkanci; S Akkaya
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

4.  Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome.

Authors:  J C Chambers; D O Haskard; J S Kooner
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

5.  Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

Authors:  S Buldanlioglu; S Turkmen; H B Ayabakan; N Yenice; M Vardar; S Dogan; E Mercan
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

6.  Impaired haemostatic kinetics and endothelial function in Behçet's disease.

Authors:  I C Haznedaroglu; O I Ozcebe; O Ozdemir; I Celik; S V Dündar; S Kirazli
Journal:  J Intern Med       Date:  1996-10       Impact factor: 8.989

7.  Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease.

Authors:  Feridun Kosar; Ibrahim Sahin; Hakan Gullu; Sengul Cehreli
Journal:  Int J Cardiol       Date:  2005-03-18       Impact factor: 4.164

8.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

9.  The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.

Authors:  Asim Orem; Y Emre Yandi; Birgül Vanizor; Gülseren Cimşit; Hüseyin Avni Uydu; Meltem Malkoç
Journal:  Clin Biochem       Date:  2002-05       Impact factor: 3.281

10.  Mortality in patients with microvascular disease.

Authors:  David S Marks; Surrendra Gudapati; L M Prisant; Brooke Weir; Caroline diDonato-Gonzalez; Jennifer L Waller; Jan L Houghton
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-06       Impact factor: 3.738

View more
  4 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

3.  Risk for Behçet's disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea.

Authors:  Yeong Ho Kim; Hyun Jee Kim; Jin Woo Park; Kyung Do Han; Yong Gyu Park; Young Bok Lee; Ji Hyun Lee
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996

4.  Evaluation of atherogenic laboratory markers in Behçet's disease patients with vascular involvement.

Authors:  Çiğdem Yücel; Ahmet Omma; Erdim Sertoğlu; Sevilay Sezer; Turan Turhan; Taner Özgürtaş
Journal:  Arch Med Sci       Date:  2019-10-27       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.